A notable trend on DAVIS is the clear advantage of graph-based drug encoders over sequence-based or handcrafted descriptors.
← all excerpts
A dual-branch graph neural network architecture for drug-target binding affinity prediction.
1
—
—
A notable trend on DAVIS is the clear advantage of graph-based drug encoders over sequence-based or handcrafted descriptors.